English to Portuguese Medical Medical: Cardiology

And then, finally, how about diabetes? We have seen a slight excess risk of diabetes in both the moderate-intensity and high-intensity statin trials. But you can't tell it apart from the background rate of diabetes. And it turns out, the only people who get diabetes on a statin are those who are going to get it anyway. And based on a number of studies, we're only moving up the diagnosis of diabetes about two months. So really, the diabetes is a non-issue, and it's really not something you should be concerned about. So this is a figure that's ***buried back*** in our guidelines because we were concerned about safety when we were thinking about "where do we draw the lines?"


Obrigado!